CD14 and primary biliary cholangitis: Notably, CD14+ monocytes were also validated as the dominant cell population in PBMCs from SLE patients, suggesting that CD14+ monocytes in PBMCs may be a key cell population for diagnosing and understanding the common pathogenesis of SLE and PBC.